DCVC Bio II, L.P. — Form D/A
DCVC Bio II, L.P. of PALO ALTO, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2020-08-04. The offering totals $350.0M, of which $350.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-08-04
- Form: D/A
- Accession: 0001812533-20-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $350.0M
- Amount sold: $350.0M
- Investors: 33
- Date of first sale: 2020-05-29
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-367880
Issuer
- Name: DCVC Bio II, L.P.
- CIK: 0001812533
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 270 UNIVERSITY AVENUE, PALO ALTO, CA, 94301
- Phone: 415-840-7337
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Zachary Bogue | Executive Officer | Palo Alto, CA |
| John Hamer | Executive Officer | Durham, NC |
| Matthew Ocko | Executive Officer | Palo Alto, CA |
| Kiersten Stead | Executive Officer | Palo Alto, CA |
Other filings by this issuer (1)
More